D. Osborne
Director of Finance/CFO at Melt Pharmaceuticals, Inc.
D. Osborne active positions
| Companies | Position | Start | End |
|---|---|---|---|
Melt Pharmaceuticals, Inc.
 Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Director of Finance/CFO | 2022-01-31 | - |
Career history of D. Osborne
Former positions of D. Osborne
| Companies | Position | Start | End |
|---|---|---|---|
| PRECIGEN, INC. | Comptroller/Controller/Auditor | 2016-03-31 | 2021-06-09 |
| Director of Finance/CFO | - | 2021-06-09 | |
| Corporate Officer/Principal | 2011-06-30 | 2016-03-31 |
Statistics
International
| United States | 3 |
Operational
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Health Technology |
- Stock Market
- Insiders
- D. Osborne
- Experience
